327 related articles for article (PubMed ID: 19204190)
1. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice.
De R; Kundu P; Swarnakar S; Ramamurthy T; Chowdhury A; Nair GB; Mukhopadhyay AK
Antimicrob Agents Chemother; 2009 Apr; 53(4):1592-7. PubMed ID: 19204190
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice.
De R; Sarkar A; Ghosh P; Ganguly M; Karmakar BC; Saha DR; Halder A; Chowdhury A; Mukhopadhyay AK
J Antimicrob Chemother; 2018 Jun; 73(6):1595-1603. PubMed ID: 29566160
[TBL] [Abstract][Full Text] [Related]
3. Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections.
Mosallam FM; Bendary MM; Elshimy R; El-Batal AI
World J Microbiol Biotechnol; 2023 Sep; 39(12):324. PubMed ID: 37773301
[TBL] [Abstract][Full Text] [Related]
4. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
[TBL] [Abstract][Full Text] [Related]
5. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.
Sarkar A; De R; Mukhopadhyay AK
World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412
[TBL] [Abstract][Full Text] [Related]
6. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases.
Mohammadi A; Khanbabaei H; Zandi F; Ahmadi A; Haftcheshmeh SM; Johnston TP; Sahebkar A
Microb Pathog; 2022 May; 166():105552. PubMed ID: 35469998
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model.
Santos AM; Lopes T; Oleastro M; Gato IV; Floch P; Benejat L; Chaves P; Pereira T; Seixas E; Machado J; Guerreiro AS
Nutrients; 2015 Jan; 7(1):306-20. PubMed ID: 25569625
[TBL] [Abstract][Full Text] [Related]
8. Selective killing of
Xiong M; Bao Y; Xu X; Wang H; Han Z; Wang Z; Liu Y; Huang S; Song Z; Chen J; Peek RM; Yin L; Chen LF; Cheng J
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12675-12680. PubMed ID: 29133389
[TBL] [Abstract][Full Text] [Related]
9. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?
Di Mario F; Cavallaro LG; Nouvenne A; Stefani N; Cavestro GM; Iori V; Maino M; Comparato G; Fanigliulo L; Morana E; Pilotto A; Martelli L; Martelli M; Leandro G; Franzè A
Helicobacter; 2007 Jun; 12(3):238-43. PubMed ID: 17493004
[TBL] [Abstract][Full Text] [Related]
10.
Huang Y; Hang X; Jiang X; Zeng L; Jia J; Xie Y; Li F; Bi H
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936098
[No Abstract] [Full Text] [Related]
11.
Xu YF; Lian DW; Chen YQ; Cai YF; Zheng YF; Fan PL; Ren WK; Fu LJ; Li YC; Xie JH; Cao HY; Tan B; Su ZR; Huang P
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320722
[TBL] [Abstract][Full Text] [Related]
12. Anti-microbial and anti-inflammatory effects of Cheonwangbosim-dan against
Park HS; Jeong HY; Kim YS; Seo CS; Ha H; Kwon HJ
J Vet Sci; 2020 May; 21(3):e39. PubMed ID: 32476313
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial action of acriflavine hydrochloride for eradication of the gastric pathogen Helicobacter pylori.
Tehlan A; Karmakar BC; Paul S; Kumar R; Kaur I; Ghosh A; Mukhopadhyay AK; Dhar SK
FEMS Microbiol Lett; 2020 Nov; 367(21):. PubMed ID: 33118020
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria.
Oyedeji KS; Smith SI; Coker AO; Arigbabu AO
Br J Biomed Sci; 2009; 66(1):10-3. PubMed ID: 19348120
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori.
Yuan Y; Wu Q; Cheng G; Liu X; Liu S; Luo J; Zhang A; Bian L; Chen J; Lv J; Dong X; Yang G; Zhu Y; Ma L
Int J Mol Med; 2015 Aug; 36(2):363-8. PubMed ID: 26080893
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial effect of Kampo herbal formulation Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang) on Helicobacter pylori infection in mice.
Yan X; Kita M; Minami M; Yamamoto T; Kuriyama H; Ohno T; Iwakura Y; Imanishi J
Microbiol Immunol; 2002; 46(7):475-82. PubMed ID: 12222933
[TBL] [Abstract][Full Text] [Related]
17. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
[TBL] [Abstract][Full Text] [Related]
18. Blue light emitting diodes enhance the antivirulence effects of Curcumin against
Darmani H; Smadi EAM; Bataineh SMB
J Med Microbiol; 2020 Apr; 69(4):617-624. PubMed ID: 32100708
[No Abstract] [Full Text] [Related]
19. Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori.
Han C; Wang L; Yu K; Chen L; Hu L; Chen K; Jiang H; Shen X
FEBS J; 2006 Oct; 273(20):4682-92. PubMed ID: 16972983
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Koosirirat C; Linpisarn S; Changsom D; Chawansuntati K; Wipasa J
Int Immunopharmacol; 2010 Jul; 10(7):815-8. PubMed ID: 20438867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
